Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and
systemic manifestations, such as anemia, fatigue, osteoporosis, and increased risk for …

Objective We performed a systematic review and meta‐analysis to evaluate the comparative
effects of tumor necrosis factor inhibitors (TNF i), non‐TNF i biologics, and conventional …

Cardiovascular disease is the leading cause of death worldwide, and its prevalence is
increasing due to the aging of societies. Atherosclerosis, a type of chronic inflammatory …

Objectives Informing an international task force updating the consensus statement on
efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) …

Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …

Background: Rheumatoid arthritis (RA) is associated with an increase in cardiovascular (CV)
risk. This issue maybe not only explained by a genetic component, as well as by the …

Accumulating observations in humans and animals indicate that inflammation plays a key
role in atherosclerosis development and subsequent complications. Moreover, the use of …

Objective These analyses aim to comparatively evaluate the persistence on treatment of
different biological disease-modifying antirheumatic drugs (bDMARDs) when administered …

Objective The aims of this study were to define the risk of serious bacterial infections in
patients receiving specific biological disease-modifying anti-rheumatic drugs (bDMARDs) …

The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive
intervention aiming to reach early and persistent low disease activity and remission. New …